NCT05971082View on ClinicalTrials.gov

Risk Factors for Advanced Fibrosis Among FLD Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Interventions
OTHER

Follow-up

Follow-up study of progression/remission of liver disease

Trial Locations (1)

Unknown

Helsinki University Hospital, Helsinki

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Helsinki University Central Hospital

OTHER